Literature DB >> 21953136

Transforming growth factor beta signaling in adult cardiovascular diseases and repair.

Thomas Doetschman1, Joey V Barnett, Raymond B Runyan, Todd D Camenisch, Ronald L Heimark, Henk L Granzier, Simon J Conway, Mohamad Azhar.   

Abstract

The majority of children with congenital heart disease now live into adulthood due to the remarkable surgical and medical advances that have taken place over the past half century. Because of this, adults now represent the largest age group with adult cardiovascular diseases. It includes patients with heart diseases that were not detected or not treated during childhood, those whose defects were surgically corrected but now need revision due to maladaptive responses to the procedure, those with exercise problems and those with age-related degenerative diseases. Because adult cardiovascular diseases in this population are relatively new, they are not well understood. It is therefore necessary to understand the molecular and physiological pathways involved if we are to improve treatments. Since there is a developmental basis to adult cardiovascular disease, transforming growth factor beta (TGFβ) signaling pathways that are essential for proper cardiovascular development may also play critical roles in the homeostatic, repair and stress response processes involved in adult cardiovascular diseases. Consequently, we have chosen to summarize the current information on a subset of TGFβ ligand and receptor genes and related effector genes that, when dysregulated, are known to lead to cardiovascular diseases and adult cardiovascular deficiencies and/or pathologies. A better understanding of the TGFβ signaling network in cardiovascular disease and repair will impact genetic and physiologic investigations of cardiovascular diseases in elderly patients and lead to an improvement in clinical interventions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21953136      PMCID: PMC3328790          DOI: 10.1007/s00441-011-1241-3

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  223 in total

1.  Molecular markers of cardiac endocardial cushion development.

Authors:  Aaron D Gitler; Min Min Lu; Yue Qin Jiang; Jonathan A Epstein; Peter J Gruber
Journal:  Dev Dyn       Date:  2003-12       Impact factor: 3.780

2.  Elastin haploinsufficiency results in progressive aortic valve malformation and latent valve disease in a mouse model.

Authors:  Robert B Hinton; Jennifer Adelman-Brown; Sandra Witt; Varun K Krishnamurthy; Hanna Osinska; Bhuvaneswari Sakthivel; Jeanne F James; Dean Y Li; Daria A Narmoneva; Robert P Mecham; D Woodrow Benson
Journal:  Circ Res       Date:  2010-06-24       Impact factor: 17.367

3.  Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta.

Authors:  K Horiuchi; N Amizuka; S Takeshita; H Takamatsu; M Katsuura; H Ozawa; Y Toyama; L F Bonewald; A Kudo
Journal:  J Bone Miner Res       Date:  1999-07       Impact factor: 6.741

4.  The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion.

Authors:  Jitesh Pratap; Amjad Javed; Lucia R Languino; Andre J van Wijnen; Janet L Stein; Gary S Stein; Jane B Lian
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

5.  The Runx transcriptional co-activator, CBFbeta, is essential for invasion of breast cancer cells.

Authors:  Daniel Mendoza-Villanueva; Wensheng Deng; Cesar Lopez-Camacho; Paul Shore
Journal:  Mol Cancer       Date:  2010-06-30       Impact factor: 27.401

Review 6.  TGF-beta1 and angiotensin networking in cardiac remodeling.

Authors:  Stephan Rosenkranz
Journal:  Cardiovasc Res       Date:  2004-08-15       Impact factor: 10.787

7.  Angiotensin II blockade and aortic-root dilation in Marfan's syndrome.

Authors:  Benjamin S Brooke; Jennifer P Habashi; Daniel P Judge; Nishant Patel; Bart Loeys; Harry C Dietz
Journal:  N Engl J Med       Date:  2008-06-26       Impact factor: 91.245

8.  Interferon-gamma and the interferon-inducible chemokine CXCL10 protect against aneurysm formation and rupture.

Authors:  Victoria L King; Alexander Y Lin; Fjoralba Kristo; Thomas J T Anderson; Neil Ahluwalia; Gregory J Hardy; A Phillip Owens; Deborah A Howatt; Dongxiao Shen; Andrew M Tager; Andrew D Luster; Alan Daugherty; Robert E Gerszten
Journal:  Circulation       Date:  2009-01-12       Impact factor: 29.690

9.  Analysis of multigenerational families with thoracic aortic aneurysms and dissections due to TGFBR1 or TGFBR2 mutations.

Authors:  V Tran-Fadulu; H Pannu; D H Kim; G W Vick; C M Lonsford; A L Lafont; C Boccalandro; S Smart; K L Peterson; J Zenger Hain; M C Willing; J S Coselli; S A LeMaire; C Ahn; P H Byers; D M Milewicz
Journal:  J Med Genet       Date:  2009-06-18       Impact factor: 6.318

10.  TGF beta in murine morphogenetic processes: the early embryo and cardiogenesis.

Authors:  R J Akhurst; S A Lehnert; A Faissner; E Duffie
Journal:  Development       Date:  1990-04       Impact factor: 6.868

View more
  46 in total

1.  Decreased levels of miR-28-5p and miR-361-3p and increased levels of insulin-like growth factor 1 mRNA in mononuclear cells from patients with hereditary hemorrhagic telangiectasia 1.

Authors:  Anthony Cannavicci; Qiuwang Zhang; Si-Cheng Dai; Marie E Faughnan; Michael J B Kutryk
Journal:  Can J Physiol Pharmacol       Date:  2018-12-04       Impact factor: 2.273

Review 2.  Clinical interpretation of genetic variants in arrhythmogenic right ventricular cardiomyopathy.

Authors:  Mireia Alcalde; Oscar Campuzano; Georgia Sarquella-Brugada; Elena Arbelo; Catarina Allegue; Sara Partemi; Anna Iglesias; Antonio Oliva; Josep Brugada; Ramon Brugada
Journal:  Clin Res Cardiol       Date:  2014-11-15       Impact factor: 5.460

3.  Diet and sex modify exercise and cardiac adaptation in the mouse.

Authors:  John P Konhilas; Hao Chen; Elizabeth Luczak; Laurel A McKee; Jessica Regan; Peter A Watson; Brian L Stauffer; Zain I Khalpey; Timothy A Mckinsey; Todd Horn; Bonnie LaFleur; Leslie A Leinwand
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-11-14       Impact factor: 4.733

Review 4.  Cardiac-specific inducible and conditional gene targeting in mice.

Authors:  Thomas Doetschman; Mohamad Azhar
Journal:  Circ Res       Date:  2012-05-25       Impact factor: 17.367

5.  Increased canonical WNT/β-catenin signalling and myxomatous valve disease.

Authors:  Sunita Chopra; Nadia Al-Sammarraie; Yimu Lai; Mohamad Azhar
Journal:  Cardiovasc Res       Date:  2017-01       Impact factor: 10.787

6.  Cardiac epithelial-mesenchymal transition is blocked by monomethylarsonous acid (III).

Authors:  Tianfang Huang; Joey V Barnett; Todd D Camenisch
Journal:  Toxicol Sci       Date:  2014-08-21       Impact factor: 4.849

Review 7.  Unmasking the molecular link between arrhythmogenic cardiomyopathy and Brugada syndrome.

Authors:  Javier Moncayo-Arlandi; Ramon Brugada
Journal:  Nat Rev Cardiol       Date:  2017-07-13       Impact factor: 32.419

Review 8.  Genetic and Developmental Basis of Cardiovascular Malformations.

Authors:  Mohamad Azhar; Stephanie M Ware
Journal:  Clin Perinatol       Date:  2016-03       Impact factor: 3.430

9.  Histone Deacetylase 3 Coordinates Deacetylase-independent Epigenetic Silencing of Transforming Growth Factor-β1 (TGF-β1) to Orchestrate Second Heart Field Development.

Authors:  Sara L Lewandowski; Harish P Janardhan; Chinmay M Trivedi
Journal:  J Biol Chem       Date:  2015-09-29       Impact factor: 5.157

10.  Common pathways regulate Type III TGFβ receptor-dependent cell invasion in epicardial and endocardial cells.

Authors:  Cynthia R Clark; Jamille Y Robinson; Nora S Sanchez; Todd A Townsend; Julian A Arrieta; W David Merryman; David Z Trykall; Harold E Olivey; Charles C Hong; Joey V Barnett
Journal:  Cell Signal       Date:  2016-03-10       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.